🇺🇸 FDA
Patent

US 9796718

6-(benzo[d]thiazol-5-yl)-n-(3,4-dimethoxyphenyl)imidazo[1,2-a]pyrazin-8-amine

granted A61KA61K31/495A61P

Quick answer

US patent 9796718 (6-(benzo[d]thiazol-5-yl)-n-(3,4-dimethoxyphenyl)imidazo[1,2-a]pyrazin-8-amine) held by GILEAD CONNECTICUT, INC. expires Mon Oct 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
GILEAD CONNECTICUT, INC.
Grant date
Tue Oct 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/495, A61P, A61P11/00, A61P11/02